These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 32030737

  • 1. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Mangaonkar AA, Thawer F, Son J, Ajebo G, Xu H, Barrett NJ, Wells LG, Bowman L, Clair B, Patel N, Bora P, Jung G, Nemeth E, Kutlar A.
    Br J Haematol; 2020 Jun; 189(6):1204-1209. PubMed ID: 32030737
    [Abstract] [Full Text] [Related]

  • 2. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
    Inomata S, Anan A, Yamauchi E, Yamauchi R, Kunimoto H, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S.
    Intern Med; 2019 Oct 15; 58(20):2915-2922. PubMed ID: 31243222
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients.
    Smesam HNK, Albuthabhak HAQ, Arjmand S, Al-Hakeim HK, R Siadat SO.
    Hemoglobin; 2020 Jul 15; 44(4):272-277. PubMed ID: 32718192
    [Abstract] [Full Text] [Related]

  • 4. Oxidative stress and hepcidin expression in pediatric sickle cell anemia with iron overload.
    Elbostany EA, Elghoroury EA, Thabet EH, Rashad AA, Rasheed EA, El-Saeed GSM, Abdelhalim DA, Abdelfattah SN, Salama II, Salama N.
    Hematol Oncol Stem Cell Ther; 2023 Apr 04; 16(3):238-244. PubMed ID: 34883086
    [Abstract] [Full Text] [Related]

  • 5. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
    El-Gamal RAE, Abdel-Messih IY, Habashy DM, Zaiema SEG, Pessar SA.
    Ann Hematol; 2020 Jan 04; 99(1):31-39. PubMed ID: 31834456
    [Abstract] [Full Text] [Related]

  • 6. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M, Fillet M, Seidel L, Jaspers A, Baron F, Beguin Y.
    Am J Hematol; 2021 Oct 01; 96(10):1275-1286. PubMed ID: 34310730
    [Abstract] [Full Text] [Related]

  • 7. Serum Hepcidin Concentration in Individuals with Sickle Cell Anemia: Basis for the Dietary Recommendation of Iron.
    Omena J, Cople-Rodrigues CDS, Cardoso JDDA, Soares AR, Fleury MK, Brito FDSB, Koury JC, Citelli M.
    Nutrients; 2018 Apr 17; 10(4):. PubMed ID: 29673144
    [Abstract] [Full Text] [Related]

  • 8. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
    Youssry I, Samy RM, AbdelMohsen M, Salama NM.
    Pediatr Res; 2024 Mar 17; 95(4):1095-1100. PubMed ID: 37464096
    [Abstract] [Full Text] [Related]

  • 9. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
    Honda H, Kobayashi Y, Onuma S, Shibagaki K, Yuza T, Hirao K, Yamamoto T, Tomosugi N, Shibata T.
    PLoS One; 2016 Mar 17; 11(3):e0151601. PubMed ID: 26978524
    [Abstract] [Full Text] [Related]

  • 10. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
    Tomczyk M, Kortas J, Flis D, Kaczorowska-Hac B, Grzybkowska A, Borkowska A, Lewicka E, Dabrowska-Kugacka A, Antosiewicz J.
    Int J Environ Res Public Health; 2020 Apr 17; 17(8):. PubMed ID: 32316587
    [Abstract] [Full Text] [Related]

  • 11. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
    Breenfeldt Andersen A, Bonne TC, Bejder J, Jung G, Ganz T, Nemeth E, Olsen NV, Huertas JR, Nordsborg NB.
    Am J Physiol Regul Integr Comp Physiol; 2021 Aug 01; 321(2):R152-R161. PubMed ID: 34160288
    [Abstract] [Full Text] [Related]

  • 12. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
    Zaman BA, Rasool SO, Abdo JM.
    Br J Haematol; 2023 May 01; 201(3):547-551. PubMed ID: 36535905
    [Abstract] [Full Text] [Related]

  • 13. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.
    Eur J Haematol; 2010 Jan 01; 84(1):72-8. PubMed ID: 19732137
    [Abstract] [Full Text] [Related]

  • 14. Iron Overload in Renal Transplant Patients: The Role of Hepcidin and Erythropoietin.
    Bilar JM, Fucuta PDS, Feldner AC, Caravalho Filho R, Silva I, Pestana JM, Ferraz ML.
    Transplant Proc; 2020 Jan 01; 52(1):169-174. PubMed ID: 31955851
    [Abstract] [Full Text] [Related]

  • 15. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
    Ghoti H, Goitein O, Koren A, Levin C, Kushnir T, Rachmilewitz E, Konen E.
    Eur J Haematol; 2010 Jan 01; 84(1):59-63. PubMed ID: 19793250
    [Abstract] [Full Text] [Related]

  • 16. Erythroferrone and hepcidin levels in children with iron deficiency anemia.
    Dulkadir R, Turna Saltoğlu G, Güneş A.
    BMC Pediatr; 2024 Apr 04; 24(1):240. PubMed ID: 38575873
    [Abstract] [Full Text] [Related]

  • 17. Iron incorporation in red blood cells of pediatric sickle cell anemia: a stable isotope pilot investigation.
    Omena J, Voll VM, Bezerra FF, Braz BF, Santelli RE, Donangelo CM, Jauregui GF, Ribeiro AS, Cople Rodrigues CDS, Citelli M.
    Eur J Clin Nutr; 2024 Sep 04; 78(9):801-807. PubMed ID: 38909172
    [Abstract] [Full Text] [Related]

  • 18. Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias.
    Ozturk Z, Gumuslu S, Yalcin K, Kupesiz A.
    J Pediatr Hematol Oncol; 2021 Jul 01; 43(5):186-192. PubMed ID: 34157011
    [Abstract] [Full Text] [Related]

  • 19. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM, Abdel-Salam A, Farhan MS, Ragab R.
    Indian J Pediatr; 2017 Oct 01; 84(10):745-750. PubMed ID: 28600663
    [Abstract] [Full Text] [Related]

  • 20. Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.
    Barcellini W, Zaninoni A, Gregorini AI, Soverini G, Duca L, Fattizzo B, Giannotta JA, Pedrotti P, Vercellati C, Marcello AP, Fermo E, Bianchi P, Cappellini MD.
    Br J Haematol; 2019 May 01; 185(3):523-531. PubMed ID: 30828802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.